Comparison Pregnancy Outcomes Between Minimal Stimulation Protocol and Conventional GnRH Antagonist Protocols in Poor Ovarian Responders

Overview

Journal J Family Reprod Health

Date 2016 Jul 8

PMID 27385972

Citations 12

Authors

Shamim Pilehvari

Ensieh ShahrokhTehraninejad

Batool Hosseinrashidi

Fatemeh Keikhah

Fedyeh Haghollahi

Elham Aziminekoo

Affiliations

Soon will be listed here.

Abstract

Objective: To compare the pregnancy outcomes achieved by in vitro fertilization (IVF) between minimal stimulation and conventional antagonist protocols in poor ovarian responders (PORs).

Materials And Methods: In this randomized controlled trial, 77 PORs undergoing IVF were selected and divided into two groups. First group was the minimal stimulation group (n = 42) receiving 100 mg/day clomiphene citrate on day 2of the cycle for 5 day that was followed by150IU/day human menopausal gonadotropin (hMG) on day 5 of the cycle. Second group was the conventional group (n = 35) receiving at least 300 IU/daygonadotropin on day 2 of the cycle. Gonadotropin-releasing hormone (GnRH) antagonist protocol was applied for both groups according to flexible protocol. Number of retrieved oocytes and chemical pregnancy rate were the main outcomes.

Results: There was no difference in number ofretrieved oocyte and pregnancy rate (2.79 ± 1.96 vs. 2.20 ± 1.71 and 5.6% vs. 4.1%; p > 0.05) between both groups. The gonadotropin dose used in the minimal stimulation group was lower than conventional group (1046 ± 596 vs. 2806 ± 583).

Conclusion: Minimal stimulation protocol with lower gonadotropin used is likely to be considered as a patient- friendly and cost-effective substitute for PORs.

Citing Articles

Young obese patients may benefit from GnRH-a long protocol contributing to higher implantation rate and live birth rate of fresh IVF-ET cycles.

Wan Q, Qian Y, Xia M, Tan L, Lv X, Meng X Heliyon. 2023; 9(10):e20016.

PMID: 37810820 PMC: 10556590. DOI: 10.1016/j.heliyon.2023.e20016.

Association between endometrial thickness before ovulation, live birth, and placenta previa rates in clomiphene citrate-treated cycles.

Nishii S, Ezoe K, Nishihara S, Onogi S, Takeshima K, Karakida S AJOG Glob Rep. 2023; 3(1):100161.

PMID: 36876159 PMC: 9975686. DOI: 10.1016/j.xagr.2023.100161.

Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study.

Liu A, Li J, Shen H, Zhang L, Li Q, Zhang X BMC Womens Health. 2022; 22(1):527.

PMID: 36528555 PMC: 9759868. DOI: 10.1186/s12905-022-02126-w.

Comparative Effectiveness of Mild or Conventional GnRH-Antagonist Protocols for Ovarian Stimulation in Poor Responders (Poseidon Group 4).

Le H, Nguyen D, Cao A, Nguyen H, Tham D, Le T Front Reprod Health. 2022; 2:606036.

PMID: 36304704 PMC: 9580736. DOI: 10.3389/frph.2020.606036.

Editorial: The Expansion of Female Fertility.

Klement A, Oron G, Bentov Y Front Reprod Health. 2022; 3:781019.

PMID: 36304019 PMC: 9580635. DOI: 10.3389/frph.2021.781019.

References

Mansour R, Aboulghar M, Serour G, Al-Inany H, Fahmy I, Amin Y . The use of clomiphene citrate/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF/ICSI program is not a cost effective protocol. Acta Obstet Gynecol Scand. 2003; 82(1):48-52. DOI: 10.1034/j.1600-0412.2003.820108.x. View

Davar R, Oskouian H, Ahmadi S, Firouzabadi R . GnRH antagonist/letrozole versus microdose GnRH agonist flare protocol in poor responders undergoing in vitro fertilization. Taiwan J Obstet Gynecol. 2010; 49(3):297-301. DOI: 10.1016/S1028-4559(10)60064-2. View

Tarlatzis B, Zepiridis L, Grimbizis G, Bontis J . Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003; 9(1):61-76. DOI: 10.1093/humupd/dmg007. View

Karimzadeh M, Mashayekhy M, Mohammadian F, Moghaddam F . Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders. Arch Gynecol Obstet. 2011; 283(5):1159-64. DOI: 10.1007/s00404-010-1828-z. View

Takasaki A, Tamura H, Taketani T, Shimamura K, Morioka H, Sugino N . A pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment. J Ovarian Res. 2013; 6(1):94. PMC: 3880974. DOI: 10.1186/1757-2215-6-94. View

Madani T, Ashrafi M, Mohammadi Yeganeh L . Comparison of different stimulation protocols efficacy in poor responders undergoing IVF: a retrospective study. Gynecol Endocrinol. 2012; 28(2):102-5. DOI: 10.3109/09513590.2011.579206. View

Garcia J, Jones G, Acosta A, Wright Jr G . Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981. Fertil Steril. 1983; 39(2):174-9. DOI: 10.1016/s0015-0282(16)46815-9. View

De Placido G, Mollo A, Alviggi C, Strina I, Varricchio M, Ranieri A . Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Hum Reprod. 2001; 16(9):1875-9. DOI: 10.1093/humrep/16.9.1875. View

Kara M, Aydin T, Aran T, Turktekin N, Ozdemir B . Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?. Eur J Obstet Gynecol Reprod Biol. 2013; 173:63-5. DOI: 10.1016/j.ejogrb.2013.11.008. View

10.

Polyzos N, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V . Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod. 2012; 27(12):3481-6. DOI: 10.1093/humrep/des318. View

11.

Ferraretti A, La Marca A, Fauser B, Tarlatzis B, Nargund G, Gianaroli L . ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011; 26(7):1616-24. DOI: 10.1093/humrep/der092. View

12.

Mohsen I, El Din R . Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI. Gynecol Endocrinol. 2012; 29(2):105-8. DOI: 10.3109/09513590.2012.730569. View

13.

Hill M, Levens E, Levy G, Ryan M, Csokmay J, DeCherney A . The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis. Fertil Steril. 2012; 97(5):1108-14.e1. DOI: 10.1016/j.fertnstert.2012.01.130. View

14.

Surrey E . Management of the poor responder: the role of GnRH agonists and antagonists. J Assist Reprod Genet. 2007; 24(12):613-9. PMC: 3455001. DOI: 10.1007/s10815-007-9180-3. View

15.

Yasa C, Bastu E, Dural O, Celik E, Ergun B . Evaluation of low-dose letrozole addition to ovulation induction in IVF. Clin Exp Obstet Gynecol. 2013; 40(1):98-100. View

16.

Kolibianakis E, Venetis C, Diedrich K, Tarlatzis B, Griesinger G . Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2009; 15(6):613-22. DOI: 10.1093/humupd/dmp026. View

17.

Cenksoy P, Ficicioglu C, Kizilkale O, Bostanci M, Bakacak M, Yesiladali M . The comparision of effect of microdose GnRH-a flare-up, GnRH antagonist/aromatase inhibitor letrozole and GnRH antagonist/clomiphene citrate protocols on IVF outcomes in poor responder patients. Gynecol Endocrinol. 2014; 30(7):485-9. DOI: 10.3109/09513590.2014.893571. View

18.

Bosdou J, Venetis C, Kolibianakis E, Toulis K, Goulis D, Zepiridis L . The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2012; 18(2):127-45. DOI: 10.1093/humupd/dmr051. View

19.

Lazer T, Dar S, Shlush E, Al Kudmani B, Quach K, Sojecki A . Comparison of IVF Outcomes between Minimal Stimulation and High-Dose Stimulation for Patients with Poor Ovarian Reserve. Int J Reprod Med. 2015; 2014:581451. PMC: 4334044. DOI: 10.1155/2014/581451. View

20.

Lee K, Kim C, Suk H, Lee Y, Kwon S, Kim S . The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization. Obstet Gynecol Sci. 2014; 57(3):216-22. PMC: 4038688. DOI: 10.5468/ogs.2014.57.3.216. View